XtenCHO™ transient expression system

XtenCHO™ Race: Revolutionizing Mammalian Protein Expression Unveiling XtenCHO™ Race XtenCHO™ Race is a next-generation mammalian expression system designed for rapid, cost-effective recombinant protein production. Optimized for small- to medium-scale production and high-throughput screening of drug candidates and protein variants, it delivers unmatched performance, leveraging 28+ years of expertise in protein expression technologies Key Advantages 1. Superior Productivity Achieves up to 10x higher yields compared to other systems.* Record-breaking results for: IgG-like antibodies (1.8 g/L for Garetosmab) Bispecific antibodies (>100 mg/L) Humanized variants (>200 mg/L) Non-antibody proteins (e.g., ACE2 >100 mg/L with enzymatic activity) 2. Extended Transient Gene Expression (TGE) Sustained plasmid retention for 14+ days through efficient transfection. Enhanced plasmid stability and protein expression without additional feeding steps. 3. Accelerated Protocol Protein harvest in just 8 days for faster turnaround times. Optimized process yielding higher expression levels. 4. Uncompromising Safety and Quality CHO cells’ inherent viral resistance ensures safer production than HEK cells. Clinical-grade protein folding and human-like post-translational modifications. 5. Simplified Workflow Fewer steps, faster production, and easy integration. Supported by a dedicated technical team. 6. Scalable & Cost-Effective Flexible production volumes from 1mL to 10L, adapting to various research needs. Biopharmaceutical-grade output at a fraction of the usual cost. 7. Rapid Global Distribution Available worldwide with 24-hour shipping. Applications in Biopharmaceutical Development With 3,500+ proteins successfully expressed, XtenCHO™ Race has proven invaluable for advancing biopharmaceutical research. It supports: Early bioanalysis to identify developability issues and optimize clinical trial success rates. High-throughput screening of drug candidates and protein variants. Production of antibodies and proteins for diagnostics, therapeutics, and structural studies. Applications in Biopharmaceutical Development XtenCHO™ Race is a game-changer for bioassay development in medicine, food safety, and environmental analysis. By replacing hybridoma-based systems, it enables: Enhanced purity, batch-to-batch consistency, and assay reliability. More cost-efficient large-scale production. Seamless integration into existing workflows. Why Choose XtenCHO™ Race? CHO-based systems drive nearly 75% of biopharmaceutical production, making them indispensable in the industry. XtenCHO™ Race maximizes these advantages, offering rapid, high-yield, and reliable protein expression to enhance your project's success. The Kit Includes: Chemically defined, animal-free expression media for optimal results. XtenCHO™ Race Enhancer to boost expression levels. Control plasmids for added flexibility and precision. Unlock the Power of XtenCHO™ Race XtenCHO™ Race combines innovation, efficiency, and scalability to redefine protein expression. Whether for therapeutic development or life science research, it empowers scientists to achieve breakthrough results with confidence. *Data based on internal studies. Results may vary depending on experimental conditions.